<?xml version='1.0' encoding='UTF-8'?>
<rss version="2.0">
  <channel>
    <title>Filtered PubMed â€“ Head and Neck Cancer</title>
    <link>https://pubmed.ncbi.nlm.nih.gov/rss/search/1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ/?limit=100</link>
    <description>Papers classified as related to head and neck cancer</description>
    <lastBuildDate>Mon, 22 Dec 2025 22:43:23 +0000</lastBuildDate>
    <item>
      <title>INDUCE-3: A randomized Phase II/III study of first-line feladilimab plus pembrolizumab in patients with recurrent/metastatic head and neck squamous cell carcinoma</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41427951/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41427951</guid>
      <description>CONCLUSIONS: This analysis does not support the combination of feladilimab plus pembrolizumab due to lack of superiority over placebo plus pembrolizumab.</description>
      <pubDate>Mon, 22 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Greater Attention to Gingival Cancer and Floor of Mouth Cancer: Based on a Retrospective Analysis of Oral Cancer Across Different Subsites</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41424359/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41424359</guid>
      <description>CONCLUSION: Gingival cancer and floor of mouth cancer have a worse prognosis, and thus require greater attention throughout the entire management process.</description>
      <pubDate>Mon, 22 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Automated Creak Identifies Laryngeal Dystonia During Conversational Speech</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41424130/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41424130</guid>
      <description>CONCLUSION: Automated creak demonstrates promise as a discriminative feature for identifying differences between speakers with AdLD from pMTD and controls in both a reading passage and conversational speech.</description>
      <pubDate>Mon, 22 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Deliverable proton conformal FLASH radiotherapy treatment planning for head and neck re-irradiation patients</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41423134/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41423134</guid>
      <description>CONCLUSIONS: - We report the deliverable proton conformal FLASH treatment plans for H&amp;amp;N re-irradiation patients using the innovative hardware configuration and measured beam data in our institution. The FLASH plans have very similar plan qualities to clinical IMPT proton plans and were deliverable with our proton machine. The machine specific 3D dose rate distribution can be calculated and displayed in the TPS.</description>
      <pubDate>Sun, 21 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Jaw-in-a-day (JIAD) for malignant indications: A systematic review</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41422685/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41422685</guid>
      <description>CONCLUSION: JIAD for HNC patients can have high success in majority of select patients/defects. Although early osseointegration rates were high, oncologic patients receiving adjuvant radiation may remain at elevated risk for ORN-associated prosthesis failure. As such, the risks and benefits of JIAD should be carefully reviewed with the patient, and cancer staging should also be considered.</description>
      <pubDate>Sun, 21 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>The actual performance of ML/AI models in predicting radiation-induced toxicity in head and neck cancer: a systematic review and meta-analysis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41421773/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41421773</guid>
      <description>An increasing number of Artificial intelligence (AI) and machine learning (ML) models are being developed to predict radiation-induced toxicities (RITs) in patients with head and neck cancer (HNC). But their performance and reliability remain uncertain. This systematic review and meta-analysis evaluated the predictive accuracy and methodological quality of these models. We comprehensively searched PubMed, EMBASE, Web of Science, and the Cochrane Library to identify studies reporting on ML/AI...</description>
      <pubDate>Sat, 20 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Development of a simplified scoring system for MRI-detected retropharyngeal lymph node features to optimize AJCC 9th edition N classification in nasopharyngeal carcinoma</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41421245/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41421245</guid>
      <description>CONCLUSIONS: High RRS was strongly correlated with inferior survival outcomes in NPC patients. Integrating high RRS into the current staging system by reclassifying these patients as N3 might improve prognostic stratification and offer more precise treatment guidance.</description>
      <pubDate>Sat, 20 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Qualitative Blinded Clinical Assessment of Automated and Manual IMPT Plans for Head and Neck Cancer</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41420630/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41420630</guid>
      <description>CONCLUSIONS: All fully automated IMPT plans for HNC were considered clinically acceptable by experienced HNC ROs. Automated plans were unanimously preferred over manually created plans in nearly all cases, with statistical significance, highlighting the clinical potential of automated IMPT planning tools.</description>
      <pubDate>Sat, 20 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Feasibility and Adherence to Home-Based Intensive Treatment Programs for Chronic Radiation-Associated Dysphagia in Head and Neck Cancer Survivors-The HIT-CRAD Trial</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41420436/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41420436</guid>
      <description>CONCLUSIONS: This study confirms the feasibility of high-volume strength and skill training with HD-tDCS in patients with C-RAD. Proactive adherence-supporting factors facilitate high adherence in this population. Both real and sham HD-tDCS proved safe, feasible, and well tolerated.</description>
      <pubDate>Sat, 20 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Influencing factors on occurrence and prognosis of oral squamous cell carcinoma after organ transplantation</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41418401/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41418401</guid>
      <description>CONCLUSION: This study emphasizes the importance of organ transplantation history in managing OSCC. Regular screening is essential for early detection and improved survival, particularly under immunosuppressive conditions, in this high-risk group.</description>
      <pubDate>Fri, 19 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Increasing Access and Quality Care for Immune Checkpoint Inhibitor-Related Thyroid Dysfunction</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41418091/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41418091</guid>
      <description>CONCLUSION: These findings suggest that an IOTOX clinic staffed by APPs using standardized algorithms with physician support effectively improved patient access to consultation and expedited the time to normalization of TFTs. This approach can serve as a framework for addressing other irAEs at our institution and has the potential to be implemented or adapted by other institutions to improve the care of patients with irAEs.</description>
      <pubDate>Fri, 19 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Investigating Early Kinetics in Plasma ctDNA and Peripheral T Cell Receptor Repertoire to Predict Treatment Outcomes to PD-1 Inhibitors in Head and Neck Cancer</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41417470/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41417470</guid>
      <description>CONCLUSIONS: Simultaneous early monitoring of ctDNA and TCR dynamics reveals key determinants of ICB outcomes in R/M HNSCC. The transient nature of TCR diversification emphasizes the importance of precise sample timing to guide early therapeutic decisions and improve patient outcomes.</description>
      <pubDate>Fri, 19 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Brain Metastases From Differentiated Thyroid Cancer in the Era of Targeted Therapies: A Multi-Center Retrospective Cohort</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41416947/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41416947</guid>
      <description>CONCLUSION: Unresected BM of DTC and those arising during systemic therapy portend high mortality.</description>
      <pubDate>Fri, 19 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Thyroid Lobectomy and Neck Dissection for N1b Papillary Thyroid Carcinoma</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41411004/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41411004</guid>
      <description>CONCLUSIONS AND RELEVANCE: This cohort study found that a select group of patients with N1b PTC treated with TL had no important difference in survival and recurrence outcomes compared with patients treated with TT + RAI. Therefore, TL is an effective and safe treatment option in carefully selected and appropriately counselled patients with N1b PTC with unilateral tumors and low-volume regional lymph node metastases without clinical extranodal extension.</description>
      <pubDate>Thu, 18 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Pathologic Response and Survival After Neoadjuvant Immunotherapy for Resectable Mucosal HNSCC: A Systematic Review and Meta-Analysis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41410931/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41410931</guid>
      <description>CONCLUSIONS AND RELEVANCE: Study findings suggest that overall PPR and MPR are associated with improved DFS. These data provide additional support for the potential use of pathologic treatment response as a surrogate for DFS after neoadjuvant ICI in resectable mucosal HNSCC.</description>
      <pubDate>Thu, 18 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Pembrolizumab in Head and Neck Cancer-Promise and Price</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41410927/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41410927</guid>
      <description>No abstract</description>
      <pubDate>Thu, 18 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>International network for sinonasal cancer research (INSICA): a collaborative group to advance research and clinical trials for rare sinonasal malignancies</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41405839/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41405839</guid>
      <description>Development of evidence-based treatment recommendations for rare cancers is challenging due to limited funding opportunities, spread of small numbers of patients across multiple institutions, and other obstacles. Malignancies of the sinonasal cavity are particularly rare with an overall incidence of approximately 0.56 cases per 100,000 population per year. Additionally, clinical behavior varies with a reported 5-year overall survival rate ranging from 22% - 67%. Here we describe our initial...</description>
      <pubDate>Wed, 17 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Mechanical Stapling Versus Hand-Sewn Technique for End-to-End Anastomosis in Free Jejunal Transfers Following Total Pharyngolaryngectomy</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41405164/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41405164</guid>
      <description>CONCLUSION: Mechanical stapling provides comparable functional outcomes to hand-sewn anastomosis while offering the advantage of shorter operative time. These findings support its use as a practical and efficient alternative for cervical esophagojejunal reconstruction following total pharyngolaryngectomy, particularly in settings seeking to optimize both efficiency and safety.</description>
      <pubDate>Wed, 17 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Differences in Survival Following Surgery Versus Chemoradiotherapy for Clinical Stage T4a Laryngeal Squamous Cell Carcinoma: A Propensity Score-Matched Analysis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41403196/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41403196</guid>
      <description>CONCLUSIONS: Surgery was associated with improved overall survival compared with definitive CRT in patients with T4a LSCC.</description>
      <pubDate>Wed, 17 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios Predict Improved Survival and Response to Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Larynx</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41403153/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41403153</guid>
      <description>CONCLUSIONS: Low NLR and high LMR were associated with favorable responses to chemotherapy and survival in LASCCL.</description>
      <pubDate>Wed, 17 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Patterns of metastasis and nodal disease in tongue and buccal carcinomas: Case-based reflections in Delhi NCR Region</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41401591/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41401591</guid>
      <description>CONCLUSION: The site and size of tumour have a significant impact on nodal dissemination in OSCC. Bilateral neck dissection can be a wise option in case of early tongue lesions involving the midline but selective unilateral dissection is adequate in selecting cases involving the buccal lesions. It is necessary to couple comorbidity profiling with imaging results when planning pre-treatment. In this study, health systems, health equity, and collaborative oncology care are strengthened.</description>
      <pubDate>Tue, 16 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Postoperative Loss of Independence in Geriatric Head and Neck Cancer Patients: A Database Study</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41400164/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41400164</guid>
      <description>CONCLUSION: Identifying patients at risk for LOI may guide surgical decision-making in older adults undergoing HNC surgery.</description>
      <pubDate>Tue, 16 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Risk Factors for &lt;em&gt;Clostridioides difficile&lt;/em&gt; Infection After Otolaryngologic Surgery: An ACS-NSQIP Analysis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41400097/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41400097</guid>
      <description>CONCLUSIONS: CDI after otolaryngologic surgery is a serious, costly complication with an incidence comparable to the national CDI rate. Knowledge of the preoperative risk factors associated with CDI may aid in the prevention of such infection after otolaryngologic procedures, thus decreasing patient morbidity and healthcare cost.</description>
      <pubDate>Tue, 16 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Capecitabine combined with immunotherapy as maintenance therapy improves survival in recurrent/metastatic nasopharyngeal carcinoma: a retrospective cohort study</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41398389/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41398389</guid>
      <description>CONCLUSION: This study provides hypothesis-generating evidence that Immu/Cape maintenance may improve survival in R/M NPC, especially for high-risk patients. Prospective, randomized trials are required to validate this strategy before it can be considered practice-changing.</description>
      <pubDate>Mon, 15 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Several Immune Checkpoint Regulators Are Associated With Poor Prognosis in Salivary Duct Carcinoma Patients</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41397444/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41397444</guid>
      <description>CONCLUSIONS AND RELEVANCE: PD-1, PD-L1, CTLA-4, and HER2 positivity are associated with unfavorable clinical outcomes in SDC. Immune checkpoint regulator expression was comparable among AR/HER2 subtypes. PD-1, PD-L1, and CTLA-4 are potential therapeutic targets for SDC, particularly for the HER2/AR double-negative subtype.</description>
      <pubDate>Mon, 15 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Head and Neck Cancer: A Review</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41396597/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41396597</guid>
      <description>CONCLUSIONS AND RELEVANCE: Head and neck cancer is the seventh most common cancer worldwide. In the US and Europe, 60% to 70% of incident oropharynx cancers are associated with HPV infection. Standard treatment for localized head and neck cancer is surgery or radiotherapy. Locoregionally advanced disease is treated with surgery followed by radiation with or without chemotherapy or concurrent chemoradiation. First-line treatment for advanced disease is immunotherapy alone or with chemotherapy.</description>
      <pubDate>Mon, 15 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Drp1 Interaction with BIP Maintains Mitochondrial Dynamic Equilibrium to Promote Anoikis Resistance and Metastasis in Nasopharyngeal Carcinoma</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41396132/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41396132</guid>
      <description>Anoikis resistance is a phenomenon wherein cells survive under anchorage-independent conditions, which is critical for cancer cell dissemination and metastasis. To identify strategies to overcome anoikis resistance, we employed a 3D suspension culture model combined with proteomic screening, identifying a relationship between the dynamin-like protein Drp1 and anoikis resistance in nasopharyngeal carcinoma (NPC). Drp1 facilitated the generation of new mitochondria and the removal of damaged ones...</description>
      <pubDate>Mon, 15 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>The Prognostic Value of Worst Pattern of Invasion-5 on Low-Risk and Early-Stage Oral Tongue Cancer</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41392798/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41392798</guid>
      <description>CONCLUSIONS: WPOI-5 is an adverse prognostic factor in pathologically early-stage, low-risk OTSCC and may justify trials of adjuvant therapy in these patients.</description>
      <pubDate>Mon, 15 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>Nomogram for Predicting Osteoradionecrosis After Fibula Free Flap for Mandibular Reconstruction</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41392779/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41392779</guid>
      <description>CONCLUSION: This is the first nomogram developed to predict ORN following fibula free flap mandibular reconstruction. It provides a personalized risk estimate, supporting individualized clinical decision-making and improved pre- and postoperative planning. Prospective validation is warranted.</description>
      <pubDate>Mon, 15 Dec 2025 06:00:00 -0500</pubDate>
    </item>
    <item>
      <title>GERD and Upper Aerodigestive Tract Cancer Risk: A Systematic Review and Meta-Analysis</title>
      <link>https://pubmed.ncbi.nlm.nih.gov/41392719/?utm_source=Other&amp;utm_medium=rss&amp;utm_campaign=None&amp;utm_content=1FKYAX__W2XmZZnH7wCJZ2gjg5p61zj0lAum4ErUZK11BzSsdZ&amp;fc=None&amp;ff=20251222174305&amp;v=2.18.0.post22+67771e2</link>
      <guid>pubmed:41392719</guid>
      <description>CONCLUSION: GERD is associated with an increased risk of laryngeal cancer. Findings support further investigation into reflux-related carcinogenesis in the UADT, particularly in high-risk populations.</description>
      <pubDate>Mon, 15 Dec 2025 06:00:00 -0500</pubDate>
    </item>
  </channel>
</rss>
